First Aid Direct All Day Pain Relief
NDC 42961-122, Naproxen Sodium, tablet, coated, from Cintas Corporation.
- Product NDC
- 42961-122
- Status
- Listed
- Labeler
- Cintas Corporation
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA204872
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42961-122 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM220 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42961-122-02 | 42961012202 | 25 PACKET in 1 BOX (42961-122-02) / 1 TABLET, COATED in 1 PACKET (42961-122-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 42961-122 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42961-122 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42961-122. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.